| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tuberous Sclerosis | 7 | 2022 | 1029 | 1.360 |
Why?
|
| Polycystic Kidney Diseases | 1 | 2022 | 133 | 0.820 |
Why?
|
| Antibodies, Antinuclear | 7 | 2009 | 326 | 0.640 |
Why?
|
| Angiomyolipoma | 4 | 2016 | 190 | 0.610 |
Why?
|
| Cysts | 1 | 2022 | 678 | 0.590 |
Why?
|
| Kidney Neoplasms | 5 | 2022 | 4262 | 0.500 |
Why?
|
| Sirolimus | 2 | 2014 | 1564 | 0.480 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2022 | 2109 | 0.410 |
Why?
|
| Lupus Erythematosus, Systemic | 7 | 2011 | 2104 | 0.340 |
Why?
|
| Immunoglobulin lambda-Chains | 4 | 2007 | 87 | 0.340 |
Why?
|
| Immunoglobulin Idiotypes | 4 | 1993 | 201 | 0.330 |
Why?
|
| Isoxazoles | 1 | 2010 | 216 | 0.330 |
Why?
|
| Immunosuppressive Agents | 2 | 2014 | 4149 | 0.330 |
Why?
|
| B-Lymphocytes | 7 | 2016 | 4665 | 0.330 |
Why?
|
| Urolithiasis | 1 | 2010 | 131 | 0.330 |
Why?
|
| Lymphangioleiomyomatosis | 2 | 2008 | 210 | 0.320 |
Why?
|
| Fructose | 1 | 2010 | 288 | 0.320 |
Why?
|
| Lupus Nephritis | 1 | 2011 | 310 | 0.310 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2011 | 604 | 0.300 |
Why?
|
| Receptors, IgG | 2 | 2009 | 582 | 0.290 |
Why?
|
| Self Tolerance | 1 | 2007 | 125 | 0.280 |
Why?
|
| Germinal Center | 2 | 2007 | 377 | 0.250 |
Why?
|
| Kidney Transplantation | 3 | 2017 | 4251 | 0.240 |
Why?
|
| Antigens, CD | 2 | 2011 | 4026 | 0.230 |
Why?
|
| Autoimmunity | 2 | 2011 | 1349 | 0.220 |
Why?
|
| Immunoglobulin Heavy Chains | 2 | 2004 | 659 | 0.220 |
Why?
|
| Complement C4 | 1 | 2002 | 257 | 0.200 |
Why?
|
| Carcinoma, Renal Cell | 3 | 2014 | 3143 | 0.200 |
Why?
|
| Genes, Immunoglobulin | 3 | 1992 | 291 | 0.200 |
Why?
|
| Immunoglobulin M | 2 | 2007 | 1537 | 0.200 |
Why?
|
| Spleen | 2 | 2007 | 2362 | 0.200 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2022 | 2849 | 0.190 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2014 | 5535 | 0.190 |
Why?
|
| Anticonvulsants | 1 | 2010 | 1916 | 0.180 |
Why?
|
| Serum Amyloid P-Component | 1 | 1999 | 47 | 0.170 |
Why?
|
| Glomerulonephritis | 2 | 2011 | 372 | 0.170 |
Why?
|
| Kidney | 3 | 2017 | 7186 | 0.160 |
Why?
|
| Mycobacterium phlei | 1 | 1998 | 2 | 0.160 |
Why?
|
| Peritoneal Dialysis, Continuous Ambulatory | 1 | 1998 | 29 | 0.160 |
Why?
|
| Nephritis, Interstitial | 1 | 1999 | 156 | 0.160 |
Why?
|
| Hyperoxaluria, Primary | 1 | 2017 | 22 | 0.150 |
Why?
|
| Mycobacterium Infections | 1 | 1998 | 119 | 0.150 |
Why?
|
| Hyperthyroidism | 1 | 1999 | 295 | 0.150 |
Why?
|
| Pseudohypoparathyroidism | 1 | 2017 | 87 | 0.140 |
Why?
|
| Oxalates | 1 | 2017 | 105 | 0.140 |
Why?
|
| Immunoglobulin G | 2 | 2013 | 4560 | 0.140 |
Why?
|
| Gelatin Sponge, Absorbable | 1 | 2016 | 60 | 0.140 |
Why?
|
| Integrin alphaV | 1 | 2016 | 55 | 0.140 |
Why?
|
| Acrylic Resins | 1 | 2016 | 142 | 0.140 |
Why?
|
| Hypocalcemia | 1 | 2017 | 191 | 0.140 |
Why?
|
| Uveitis | 1 | 1999 | 375 | 0.130 |
Why?
|
| Deglutition | 1 | 2017 | 197 | 0.130 |
Why?
|
| Antigen-Antibody Complex | 2 | 2011 | 517 | 0.130 |
Why?
|
| Peritonitis | 1 | 1998 | 365 | 0.130 |
Why?
|
| Mice, Inbred BALB C | 4 | 2011 | 6386 | 0.130 |
Why?
|
| Immune Tolerance | 1 | 2004 | 2258 | 0.130 |
Why?
|
| Gelatin | 1 | 2016 | 225 | 0.120 |
Why?
|
| DNA | 4 | 2002 | 7301 | 0.120 |
Why?
|
| Kidney Glomerulus | 2 | 2011 | 697 | 0.120 |
Why?
|
| Kidney Failure, Chronic | 2 | 2017 | 2538 | 0.120 |
Why?
|
| Mice, Knockout | 7 | 2016 | 14557 | 0.120 |
Why?
|
| Mice, 129 Strain | 2 | 2011 | 386 | 0.110 |
Why?
|
| Teichoic Acids | 1 | 2013 | 66 | 0.110 |
Why?
|
| Immunoglobulin Variable Region | 2 | 1991 | 421 | 0.110 |
Why?
|
| Mannose-Binding Lectins | 1 | 2013 | 100 | 0.110 |
Why?
|
| Antibodies, Anti-Idiotypic | 2 | 2013 | 349 | 0.110 |
Why?
|
| Toll-Like Receptors | 1 | 2016 | 592 | 0.110 |
Why?
|
| Airway Obstruction | 1 | 2017 | 664 | 0.100 |
Why?
|
| Immunoglobulin Constant Regions | 1 | 1991 | 59 | 0.100 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 2011 | 159 | 0.100 |
Why?
|
| TRPP Cation Channels | 1 | 2011 | 176 | 0.100 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2016 | 1086 | 0.090 |
Why?
|
| Cell Wall | 1 | 2013 | 422 | 0.090 |
Why?
|
| Protein Transport | 1 | 2016 | 1988 | 0.090 |
Why?
|
| B-Cell Activating Factor | 1 | 2009 | 119 | 0.080 |
Why?
|
| Fear | 1 | 2017 | 1440 | 0.080 |
Why?
|
| Genes, Recessive | 1 | 2011 | 641 | 0.080 |
Why?
|
| Autoantibodies | 3 | 2011 | 2035 | 0.080 |
Why?
|
| Chromatin | 1 | 1999 | 2934 | 0.070 |
Why?
|
| Immunoglobulin D | 1 | 2007 | 56 | 0.070 |
Why?
|
| Antibodies, Antiphospholipid | 1 | 2007 | 69 | 0.070 |
Why?
|
| Receptors, Complement 3d | 1 | 2007 | 118 | 0.070 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2013 | 687 | 0.070 |
Why?
|
| Embolization, Therapeutic | 1 | 2016 | 1392 | 0.070 |
Why?
|
| Syndecan-1 | 1 | 2007 | 165 | 0.070 |
Why?
|
| Liver Transplantation | 1 | 2017 | 2119 | 0.070 |
Why?
|
| Mice | 9 | 2016 | 81183 | 0.070 |
Why?
|
| Receptors, IgE | 1 | 2007 | 389 | 0.060 |
Why?
|
| Base Sequence | 5 | 2004 | 12797 | 0.060 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Light Chain | 1 | 2004 | 18 | 0.060 |
Why?
|
| Staphylococcal Infections | 1 | 2013 | 1400 | 0.060 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Heavy Chain | 1 | 2004 | 92 | 0.060 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 2004 | 173 | 0.060 |
Why?
|
| Respiratory Function Tests | 1 | 2008 | 1616 | 0.060 |
Why?
|
| Lung Neoplasms | 1 | 2008 | 13102 | 0.060 |
Why?
|
| Molecular Sequence Data | 4 | 2004 | 18111 | 0.060 |
Why?
|
| Mice, Transgenic | 2 | 2007 | 9734 | 0.050 |
Why?
|
| Female | 14 | 2022 | 380194 | 0.050 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2002 | 226 | 0.050 |
Why?
|
| Lymphocyte Activation | 2 | 2004 | 5524 | 0.050 |
Why?
|
| Immunophenotyping | 1 | 2007 | 1880 | 0.050 |
Why?
|
| Male | 12 | 2022 | 350118 | 0.050 |
Why?
|
| Receptors, Cell Surface | 1 | 2011 | 2866 | 0.050 |
Why?
|
| Crosses, Genetic | 1 | 2002 | 791 | 0.050 |
Why?
|
| Amino Acid Sequence | 3 | 2004 | 13815 | 0.050 |
Why?
|
| Humans | 23 | 2022 | 744343 | 0.050 |
Why?
|
| Polymorphism, Genetic | 1 | 1991 | 4328 | 0.050 |
Why?
|
| Animals | 11 | 2016 | 168757 | 0.050 |
Why?
|
| Diagnosis, Differential | 2 | 2017 | 12959 | 0.050 |
Why?
|
| Protein Kinases | 1 | 2008 | 1640 | 0.050 |
Why?
|
| Antibody Specificity | 1 | 2002 | 1095 | 0.050 |
Why?
|
| Child | 6 | 2017 | 77709 | 0.040 |
Why?
|
| Integrin alphaXbeta2 | 1 | 1999 | 29 | 0.040 |
Why?
|
| Tumor Burden | 2 | 2016 | 1915 | 0.040 |
Why?
|
| Bone Marrow Transplantation | 1 | 2007 | 2765 | 0.040 |
Why?
|
| Age Factors | 4 | 2016 | 18370 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2011 | 5985 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2010 | 8642 | 0.040 |
Why?
|
| Dendritic Cells | 1 | 2009 | 2725 | 0.040 |
Why?
|
| Homeodomain Proteins | 1 | 2007 | 2421 | 0.040 |
Why?
|
| Hyperoxaluria | 1 | 2017 | 32 | 0.040 |
Why?
|
| Kidney Diseases | 1 | 2008 | 2149 | 0.040 |
Why?
|
| Phosphorus | 1 | 2017 | 338 | 0.030 |
Why?
|
| Integrin beta3 | 1 | 2016 | 122 | 0.030 |
Why?
|
| Syndrome | 2 | 1999 | 3251 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 1996 | 351 | 0.030 |
Why?
|
| Hypoparathyroidism | 1 | 1996 | 120 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2002 | 2216 | 0.030 |
Why?
|
| Dyspnea | 1 | 2002 | 1303 | 0.030 |
Why?
|
| Epilepsy | 1 | 2010 | 3310 | 0.030 |
Why?
|
| Poland | 1 | 2014 | 184 | 0.030 |
Why?
|
| Injections, Intradermal | 1 | 2013 | 117 | 0.030 |
Why?
|
| Thyrotropin | 1 | 2017 | 849 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2002 | 2418 | 0.030 |
Why?
|
| Cloning, Molecular | 2 | 1991 | 4320 | 0.030 |
Why?
|
| Mannose-Binding Lectin | 1 | 2013 | 150 | 0.030 |
Why?
|
| Catheterization | 1 | 1998 | 1470 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 18029 | 0.030 |
Why?
|
| Particle Size | 1 | 2016 | 1642 | 0.030 |
Why?
|
| Adolescent | 6 | 2017 | 85781 | 0.020 |
Why?
|
| Complement Activation | 1 | 2013 | 453 | 0.020 |
Why?
|
| Inbreeding | 1 | 2011 | 49 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1992 | 708 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 1996 | 1401 | 0.020 |
Why?
|
| Mice, Congenic | 1 | 2011 | 99 | 0.020 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2013 | 288 | 0.020 |
Why?
|
| Nephrectomy | 1 | 2017 | 1050 | 0.020 |
Why?
|
| Renal Insufficiency | 1 | 2017 | 804 | 0.020 |
Why?
|
| Infant | 2 | 2010 | 35136 | 0.020 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1991 | 768 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2013 | 21827 | 0.020 |
Why?
|
| Immune Complex Diseases | 1 | 1990 | 54 | 0.020 |
Why?
|
| Myeloma Proteins | 1 | 1990 | 72 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2010 | 41006 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2016 | 1970 | 0.020 |
Why?
|
| Glomerulonephritis, IGA | 1 | 1990 | 66 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2017 | 2170 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2014 | 11366 | 0.020 |
Why?
|
| Immunization | 1 | 2013 | 1256 | 0.020 |
Why?
|
| Histones | 1 | 1999 | 2599 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 3870 | 0.020 |
Why?
|
| Vitamins | 1 | 2017 | 1622 | 0.020 |
Why?
|
| Abnormalities, Multiple | 1 | 1996 | 1416 | 0.020 |
Why?
|
| China | 1 | 2014 | 2248 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2016 | 5179 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 1992 | 2256 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2016 | 77449 | 0.020 |
Why?
|
| Autophagy | 1 | 2016 | 1300 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2014 | 2649 | 0.020 |
Why?
|
| Weight Loss | 1 | 1999 | 2622 | 0.020 |
Why?
|
| Risk Factors | 2 | 2016 | 72290 | 0.020 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2002 | 3047 | 0.020 |
Why?
|
| Renal Dialysis | 1 | 2017 | 1786 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 2014 | 1547 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2002 | 19229 | 0.020 |
Why?
|
| Epitopes | 1 | 1993 | 2571 | 0.020 |
Why?
|
| Mutation | 3 | 2004 | 29786 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 1999 | 5021 | 0.020 |
Why?
|
| Interferons | 1 | 2009 | 706 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2016 | 5974 | 0.020 |
Why?
|
| Haplotypes | 1 | 1991 | 2779 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2014 | 15076 | 0.020 |
Why?
|
| Brain | 1 | 2011 | 26385 | 0.020 |
Why?
|
| Calcium | 1 | 2017 | 5756 | 0.010 |
Why?
|
| Vitamin D | 1 | 2017 | 3223 | 0.010 |
Why?
|
| Interleukin-10 | 1 | 2009 | 1200 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2017 | 4286 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1992 | 6171 | 0.010 |
Why?
|
| Apoptosis | 1 | 1999 | 9727 | 0.010 |
Why?
|
| Alleles | 2 | 1991 | 6933 | 0.010 |
Why?
|
| Prognosis | 2 | 2014 | 29063 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2016 | 10481 | 0.010 |
Why?
|
| Autoimmune Diseases | 1 | 1992 | 2133 | 0.010 |
Why?
|
| Gene Expression | 1 | 1992 | 7799 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2009 | 3200 | 0.010 |
Why?
|
| Young Adult | 2 | 2016 | 56430 | 0.010 |
Why?
|
| Time Factors | 2 | 2016 | 40075 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 1992 | 13033 | 0.010 |
Why?
|
| Adult | 5 | 2016 | 214055 | 0.010 |
Why?
|
| Drosophila | 1 | 1985 | 1491 | 0.010 |
Why?
|
| Adaptation, Psychological | 1 | 1988 | 2576 | 0.010 |
Why?
|
| Health Status Indicators | 1 | 2002 | 969 | 0.010 |
Why?
|
| Middle Aged | 4 | 2016 | 213383 | 0.010 |
Why?
|
| Family | 1 | 1988 | 3147 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2002 | 2886 | 0.010 |
Why?
|
| Facial Bones | 1 | 1996 | 201 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2016 | 20129 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1988 | 3336 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2016 | 23403 | 0.010 |
Why?
|
| Sex Factors | 1 | 2006 | 10397 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 2006 | 25625 | 0.010 |
Why?
|
| Genotype | 1 | 2006 | 12951 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2009 | 12072 | 0.010 |
Why?
|
| Antibody Diversity | 1 | 1990 | 74 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2016 | 63114 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 35421 | 0.010 |
Why?
|
| Aged | 2 | 2016 | 163280 | 0.010 |
Why?
|
| Incidence | 1 | 2006 | 20947 | 0.000 |
Why?
|
| Autoantigens | 1 | 1992 | 892 | 0.000 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 14722 | 0.000 |
Why?
|
| Gene Rearrangement | 1 | 1992 | 1179 | 0.000 |
Why?
|
| United States | 1 | 2014 | 69872 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 2002 | 19905 | 0.000 |
Why?
|
| Recurrence | 1 | 1996 | 8340 | 0.000 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1985 | 1375 | 0.000 |
Why?
|
| Nervous System | 1 | 1985 | 554 | 0.000 |
Why?
|
| Embryo, Nonmammalian | 1 | 1985 | 895 | 0.000 |
Why?
|
| Lymphoma | 1 | 1990 | 1877 | 0.000 |
Why?
|
| Tissue Distribution | 1 | 1985 | 2327 | 0.000 |
Why?
|
| Heart Defects, Congenital | 1 | 1996 | 4584 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2002 | 57776 | 0.000 |
Why?
|
| Patient Compliance | 1 | 1988 | 2684 | 0.000 |
Why?
|
| RNA | 1 | 1985 | 2749 | 0.000 |
Why?
|
| Transcription, Genetic | 1 | 1985 | 7722 | 0.000 |
Why?
|